TIS 0.00% 0.0¢ tissue therapies limited

risks, page-6

  1. 426 Posts.
    I agree the other hurdle is a negotiation.
    If the big partners can not see a way to turn a dime out of this, then it doesn't matter how good it is, they will not sign up.
    Also if TIS fail to get a good deal, then the product could be a hit and we still not see much of it.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.